Gustavo J. Pesquin is the CEO of Amneal Pharmaceuticals, where he focuses on commercial operations. He has a solid track record in the pharmaceutical industry, previously working for Sanofi for 11 years, where he led their North America General Medicines...
Gustavo J. Pesquin is the CEO of Amneal Pharmaceuticals, where he focuses on commercial operations. He has a solid track record in the pharmaceutical industry, previously working for Sanofi for 11 years, where he led their North America General Medicines division. Gustavo has a strong academic background with an M.B.A. from Northwestern University's Kellogg School and a degree from Universidad Nacional de Cuyo in Argentina. His hiring as Executive Vice President and Chief Commercial Officer in September 2022 marked a strategic move for Amneal, pointing towards growth in specialty pharmaceuticals. Gustavo's leadership style emphasizes results, as reflected in the bonus structure tied to company performance metrics like revenue growth and EBITDA. Under his guidance, Amneal aims to innovate and expand in the competitive pharma landscape. He holds significant stock in the company, highlighting his belief in Amneal's potential and aligning his interests with shareholders. With a wealth of experience across various influential roles in well-known companies, he continues to lead Amneal with a focus on delivering value to both customers and investors.